Permanens Capital’s Bristol-Myers Squibb BMY Stock Holding History

Permanens Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-102	Closed	-$7K	–	49
2021 Q2	$7K	Hold	102	–	–	﹤0.01%	82
2021 Q1	$6K	Hold	102	–	–	﹤0.01%	102
2020 Q4	$6K	Hold	102	–	–	﹤0.01%	104
2020 Q3	$6K	Hold	102	–	–	﹤0.01%	94
2020 Q2	$6K	Hold	102	–	–	﹤0.01%	89
2020 Q1	$6K	Hold	102	–	–	﹤0.01%	89
2019 Q4	$7K	Hold	102	–	–	﹤0.01%	109
2019 Q3	$5K	Hold	102	–	–	﹤0.01%	79
2019 Q2	$5K	Sell	102 -20,000	-99%	-$932K	﹤0.01%	80
2019 Q1	$959K	Buy	+20,102	New	+$1M	0.28%	20

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Permanens Capital's BMY Position: Q3 2021 in Review

Permanens Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 102 shares — an estimated $7K sold.

Permanens Capital first reported a position in BMY in Q1 2019 and held it in 10 quarters. The position peaked at $959K in Q1 2019. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Permanens Capital reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
Permanens Capital sold 102 Bristol-Myers Squibb shares in Q3 2021, an estimated $7K.
Permanens Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 10 quarters.
Permanens Capital's Bristol-Myers Squibb position peaked at $959K in Q1 2019.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Permanens Capital's 13F filing for Q3 2021, filed 12 Nov 2021.